SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-010876
Filing Date
2021-08-09
Accepted
2021-08-09 07:31:23
Documents
60
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q zyne-20210630x10q.htm   iXBRL 10-Q 1130450
2 EX-3.1 zyne-20210630xex3d1.htm EX-3.1 145745
3 EX-10.2 zyne-20210630xex10d2.htm EX-10.2 61904
4 EX-31.1 zyne-20210630xex31d1.htm EX-31.1 11546
5 EX-31.2 zyne-20210630xex31d2.htm EX-31.2 11283
6 EX-32.1 zyne-20210630xex32d1.htm EX-32.1 6085
7 EX-32.2 zyne-20210630xex32d2.htm EX-32.2 6106
  Complete submission text file 0001558370-21-010876.txt   5377919

Data Files

Seq Description Document Type Size
8 EX-101.SCH zyne-20210630.xsd EX-101.SCH 36077
9 EX-101.CAL zyne-20210630_cal.xml EX-101.CAL 44105
10 EX-101.DEF zyne-20210630_def.xml EX-101.DEF 125714
11 EX-101.LAB zyne-20210630_lab.xml EX-101.LAB 314160
12 EX-101.PRE zyne-20210630_pre.xml EX-101.PRE 258929
13 EXTRACTED XBRL INSTANCE DOCUMENT zyne-20210630x10q_htm.xml XML 988997
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37526 | Film No.: 211154634
SIC: 2834 Pharmaceutical Preparations